γ-aminobutyric acid regulates both the survival and replication of human β-cells

Diabetes

Volumn 62, Issue 11, 2013, Pages 3760-3765

  Tian, Jide ^a   Dang, Hoa ^a   Chen, Zheying ^a   Guan, Alice ^a   Jin, Yingli ^a   Atkinson, Mark A ^b   Kaufman, Daniel L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; 4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID B RECEPTOR; MUSCIMOL; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; BACLOFEN;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CELL DIVISION; CELL SURVIVAL; HUMAN; HUMAN CELL; HYPERGLYCEMIA; HYPOXIA; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANIMAL; DRUG EFFECTS; EXPERIMENTAL DIABETES MELLITUS; MALE; NONOBESE DIABETIC MOUSE; PATHOLOGY; PHYSIOLOGY; XENOGRAFT; DRUG EFFECT;

ANIMALS; APOPTOSIS; BACLOFEN; CELL SURVIVAL; DIABETES MELLITUS, EXPERIMENTAL; GABA-A RECEPTOR AGONISTS; GAMMA-AMINOBUTYRIC ACID; HETEROGRAFTS; HUMANS; INSULIN-SECRETING CELLS; ISLETS OF LANGERHANS TRANSPLANTATION; MALE; MICE; MICE, INBRED NOD; MUSCIMOL; RECEPTORS, GABA-A;

EID: 84891715964     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-0931     Document Type: Article

References (25)

1. Ligon B, Yang J, Morin SB, Ruberti MF, Steer ML. Regulation of pancreatic islet cell survival and replication by gamma-aminobutyric acid. Diabetologia 2007;50:764-773
2. Soltani N, Qiu H, Aleksic M, et al. GABA exerts protective and regenerative effects on islet beta cells and reverses diabetes. Proc Natl Acad Sci USA 2011;108:11692-11697
3. Ge S, Pradhan DA, Ming GL, Song H. GABA sets the tempo for activitydependent adult neurogenesis. Trends Neurosci 2007;30:1-8
4. Yuan TF. GABA effects on neurogenesis: an arsenal of regulation. Sci Signal 2008;1:jc1
5. Ikeda Y, Nishiyama N, Saito H, Katsuki H. GABAA receptor stimulation promotes survival of embryonic rat striatal neurons in culture. Brain Res Dev Brain Res 1997;98:253-258
6. Fiszman ML, Borodinsky LN, Neale JH. GABA induces proliferation of immature cerebellar granule cells grown in vitro. Brain Res Dev Brain Res 1999;115:1-8
7. Nakamichi N, Takarada T, Yoneda Y. Neurogenesis mediated by gammaaminobutyric acid and glutamate signaling. J Pharmacol Sci 2009;110:133- 149
8. Cesetti T, Fila T, Obernier K, et al. GABAA receptor signaling induces osmotic swelling and cell cycle activation of neonatal prominin+ precursors. Stem Cells 2011;29:307-319
9. Bonner-Weir S, Li WC, Ouziel-Yahalom L, Guo L, Weir GC, Sharma A. Betacell growth and regeneration: replication is only part of the story. Diabetes 2010;59:2340-2348
10. Kulkarni RN, Mizrachi EB, Ocana AG, Stewart AF. Human β-cell proliferation and intracellular signaling: driving in the dark without a road map. Diabetes 2012;61:2205-2213
11. The Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 2000;342:381-389
12. Biarnés M, Montolio M, Nacher V, Raurell M, Soler J, Montanya E. Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia. Diabetes 2002;51:66-72
13. Emamaullee JA, Shapiro AM. Factors influencing the loss of beta-cell mass in islet transplantation. Cell Transplant 2007;16:1-8
14. Davalli AM, Ogawa Y, Ricordi C, Scharp DW, Bonner-Weir S, Weir GC. A selective decrease in the beta cell mass of human islets transplanted into diabetic nude mice. Transplantation 1995;59:817-820
15. Tian J, Chau C, Hales TG, Kaufman DL. GABA(A) receptors mediate inhibition of T cell responses. J Neuroimmunol 1999;96:21-28
16. Tian J, Lu Y, Zhang H, Chau CH, Dang HN, Kaufman DL. Gamma-aminobutyric acid inhibits T cell autoimmunity and the development of inflammatory responses in a mouse type 1 diabetes model. J Immunol 2004;173:5298- 5304
17. Tian J, Yong J, Dang H, Kaufman DL. Oral GABA treatment downregulates inflammatory responses in a mouse model of rheumatoid arthritis. Autoimmunity 2011;44:465-470
18. Tian J, Dang H, Yong J, et al. Oral treatment with g-aminobutyric acid improves glucose tolerance and insulin sensitivity by inhibiting inflammation in high fat diet-fed mice. PloS One 2011;6:e25338
19. Bhat R, Axtell R, Mitra A, et al. Inhibitory role for GABA in autoimmune inflammation. Proc Natl Acad Sci USA 2010;107:2580-2585
20. Tian J, Dang H, Kaufman DL. Combining antigen-based therapy with GABA treatment synergistically prolongs survival of transplanted ß-cells in diabetic NOD mice. PLoS One 2011;6:e25337
21. Sherry NA, Kushner JA, Glandt M, Kitamura T, Brillantes AM, Herold KC. Effects of autoimmunity and immune therapy on beta-cell turnover in type 1 diabetes. Diabetes 2006;55:3238-3245
22. Otomo E, Araki G, Mori A, Kurihara M. Clinical evaluation of GABA in the treatment of cerebrovascular disorders. Multi-center double-blind study in comparison with pyrithioxine and placebo. Arzneimittelforschung 1981;31: 1511-1523
23. Loeb C, Benassi E, Bo GP, Cocito L, Maffini M, Scotto P. Preliminary evaluation of the effect of GABA and phosphatidylserine in epileptic patients. Epilepsy Res 1987;1:209-212
24. Tower DB, Roberts E. Inhibition in the Nervous System and GABA. New York, Pergamon Press, 1960, p. 562-578
25. Kuriyama K, Sze PY. Blood-brain barrier to H3-gamma-aminobutyric acid in normal and amino oxyacetic acid-treated animals. Neuropharmacology 1971;10:103-108